share_log

UBS Downgrades CareMax to Neutral, Lowers Price Target to $1

Benzinga ·  Nov 17, 2023 18:01

UBS analyst A.J. Rice downgrades CareMax (NASDAQ:CMAX) from Buy to Neutral and lowers the price target from $5 to $1.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment